264 results
Page 4 of 14
8-K
EX-99.2
zc3p7zd
11 Jan 21
Axogen Reports Preliminary Unaudited Revenue
7:15am
8-K
EX-99.1
azai12n2lffbdr8
11 Jan 21
Axogen Reports Preliminary Unaudited Revenue
7:15am
424B3
oa6rfu7jp8infx b19
8 Jan 21
Prospectus supplement
5:29pm
8-K
EX-10.1
0vjnegjbur
6 Jan 21
Departure of Directors or Certain Officers
5:21pm
8-K
EX-10.2
9it60
29 Oct 20
Axogen, Inc. Reports Third Quarter 2020 Financial Results
5:02pm
8-K
EX-10.6
xz679k4vr0z
29 Oct 20
Axogen, Inc. Reports Third Quarter 2020 Financial Results
5:02pm
8-K
EX-99.1
acgcewflhyma1vuyon
29 Oct 20
Axogen, Inc. Reports Third Quarter 2020 Financial Results
5:02pm
8-K
EX-10.1
8hlphqqw4ic0gwg2nia
29 Oct 20
Axogen, Inc. Reports Third Quarter 2020 Financial Results
5:02pm
8-K
EX-10.3
qsm 0dhkyg2
29 Oct 20
Axogen, Inc. Reports Third Quarter 2020 Financial Results
5:02pm
8-K
EX-10.7
asclbm3vvd
29 Oct 20
Axogen, Inc. Reports Third Quarter 2020 Financial Results
5:02pm
8-K
EX-10.4
8f1yp0tpzd8 ew8xzyf
29 Oct 20
Axogen, Inc. Reports Third Quarter 2020 Financial Results
5:02pm
8-K
EX-10.5
y9kpdv8235
29 Oct 20
Axogen, Inc. Reports Third Quarter 2020 Financial Results
5:02pm
8-K
g7v 7llkyfcr
15 Sep 20
Regulation FD Disclosure
4:12pm
8-K
EX-99.1
ejpoyr1t
22 Jul 20
Axogen RECONSM Clinical Study Completes Target Enrollment of 220 Subjects
7:11am
8-K
EX-10.1
x80r6cy937sppiz3gtd
1 Jul 20
Axogen Announces New Seven-Year Financing Agreement with Oberland Capital and Provides Preliminary Second Quarter Revenue Estimate
7:11am
8-K
EX-10.2
viqh0etcj0d 6b
1 Jul 20
Axogen Announces New Seven-Year Financing Agreement with Oberland Capital and Provides Preliminary Second Quarter Revenue Estimate
7:11am
8-K
EX-99.1
yhbs563uq0mhu6o
1 Jul 20
Axogen Announces New Seven-Year Financing Agreement with Oberland Capital and Provides Preliminary Second Quarter Revenue Estimate
7:11am